Unknown

Dataset Information

0

Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection.


ABSTRACT: The cornea is essential for vision yet highly sensitive to immune-mediated damage following infection. Generating vaccines that provide sterile immunity against ocular surface pathogens without evoking vision loss is therefore clinically challenging. Here, we tested a prophylactic live-attenuated vaccine against herpes simplex virus type 1 (HSV-1), a widespread human pathogen that can cause corneal blindness. Parenteral vaccination of mice resulted in sterile immunity to subsequent HSV-1 challenge in the cornea and suppressed productive infection of the nervous system. This protection was unmatched by a relevant glycoprotein subunit vaccine. Efficacy of the live-attenuated vaccine involved a T-dependent humoral immune response and complement C3 but not Fc?-receptor 3 or interferon-?/? signaling. Proteomic analysis of viral proteins recognized by antiserum revealed an unexpected repertoire dominated by sequestered antigens rather than surface-exposed envelope glycoproteins. Ocular HSV-1 challenge in naive and subunit-vaccinated mice triggered vision loss and severe ocular pathologies including corneal opacification, scar formation, neovascularization, and sensation loss. However, corneal pathology was absent in mice receiving the live-attenuated vaccine concomitant with complete preservation of visual acuity. Collectively, this is the first comprehensive report of a prophylactic vaccine candidate that elicits resistance to ocular HSV-1 infection while fully preserving the cornea and visual acuity.

SUBMITTER: Royer DJ 

PROVIDER: S-EPMC6462227 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection.

Royer Derek J DJ   Hendrix Joshua F JF   Larabee Chelsea M CM   Reagan Alaina M AM   Sjoelund Virginie H VH   Robertson Danielle M DM   Carr Daniel J J DJJ  

Mucosal immunology 20190122 3


The cornea is essential for vision yet highly sensitive to immune-mediated damage following infection. Generating vaccines that provide sterile immunity against ocular surface pathogens without evoking vision loss is therefore clinically challenging. Here, we tested a prophylactic live-attenuated vaccine against herpes simplex virus type 1 (HSV-1), a widespread human pathogen that can cause corneal blindness. Parenteral vaccination of mice resulted in sterile immunity to subsequent HSV-1 challen  ...[more]

Similar Datasets

| S-EPMC6492284 | biostudies-literature
| S-EPMC6909011 | biostudies-literature
| S-EPMC7004361 | biostudies-literature
| S-EPMC4516015 | biostudies-literature
| S-EPMC4431768 | biostudies-literature
| S-EPMC5082835 | biostudies-literature
| S-EPMC4468912 | biostudies-literature
| S-EPMC7273502 | biostudies-literature
| S-EPMC9478384 | biostudies-literature
| S-EPMC8061756 | biostudies-literature